423 A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer

• Lawrence Fong,
• Russell Pachynski,
• Peter Oppelt,
• Melissa Reimers,
• Cody Weimholt,
• Katie Slane,
• Jason Frankel,
• Robert Figenshau,
• Eric Kim,
• Gerald Andriole

Affiliations

Lawrence Fong

University of California San Francisco, San Francisco, California, USA

Russell Pachynski

3Washington University School of Medicine, St Louis, MO, USA

Peter Oppelt

Department of Obstetrics, Johannes Kepler University Linz, Linz, Austria

Melissa Reimers

1Washington University School of Medicine, St Louis, MO, USA

Cody Weimholt

1Washington University School of Medicine, St Louis, MO, USA

Katie Slane

1Washington University School of Medicine, St Louis, MO, USA

Jason Frankel

1Washington University School of Medicine, St Louis, MO, USA

Robert Figenshau

1Washington University School of Medicine, St Louis, MO, USA

Eric Kim

1Washington University School of Medicine, St Louis, MO, USA

Gerald Andriole

1Washington University School of Medicine, St Louis, MO, USA